CDT
Conduit Pharmaceuticals Inc.
NASDAQ: CDT · HEALTHCARE · BIOTECHNOLOGY
$2.25
-8.55% today
Updated 2026-04-29
Market cap
$13.36M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1,177.89
Dividend yield
—
52W range
$2 – $1,754
Volume
0.4M
Conduit Pharmaceuticals Inc. (CDT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-2.15M | $-2.27M | $-7.72M | $-9.68M | $-15.55M |
| Capital expenditures | $5.00 | $0.00 | $0.00 | $51000.00 | $2.40M |
| Depreciation | — | — | — | — | — |
| Stock-based comp | — | $0.00 | $199000.00 | $1.63M | $2.18M |
| Free cash flow | $-2.15M | $-2.27M | $-7.72M | $-9.73M | $-17.96M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | $8.20M | $7.97M |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |